Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A

Journal of Clinical Investigation

Volumn 103, Issue 9, 1999, Pages 1253-1260

  Kawaguchi, Yasushi ^a,b   Hara, Masako ^b   Wright, Timothy M ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR A; ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 1; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PRIMER DNA; PROCOLLAGEN;

ARTICLE; COLLAGEN SYNTHESIS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; SKIN;

BASE SEQUENCE; DNA PRIMERS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; OLIGONUCLEOTIDES, ANTISENSE; PLATELET-DERIVED GROWTH FACTOR; PROCOLLAGEN; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0033121274     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4304     Document Type: Article

References (40)

1. Medsger, T.A., Jr. 1993. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In Arthritis and allied conditions. D.J. McCarty and W.J. Koopman, editors. Lea & Febiger. Philadelphia, PA. 1253-1292.
2. Rodnan, G.P., Lipinski, E., and Luksick, J. 1979. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 22:130-140.
3. LeRoy, E.C. 1974. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblasts. J. Clin. Invest. 54:880-889.
4. Buckingham, R.B., Prince, R.K., Rodnan, G.P., and Taylor, F. 1978. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J. Lab. Clin. Med. 92:5-21.
5. Kulozik, M., Hogg, A., Lankat-Buttgereit, B., and Krieg, T. 1990. Co-localization of transforming growth factor b2 with a1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest. 86:917-922.
6. Trojanowska, M., Wu, L., and LeRoy, E.C. 1988. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts. Oncogene. 3:477-481.
7. Whiteside, T.L., Ferrarini, M., Hebda, P., and Buckingham, R.B. 1988. Heterogenous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissue. Arthritis Rheum. 31:1221-1229.
8. Yamakage, A., Kikuchi, K., Smith, E.A., LeRoy, E.C., and Trojanowska, M. 1992. Selective upregulation of platelet-derived growth factor a receptors by transforming growth factor b in scleroderma fibroblasts. J. Exp. Med. 175:1227-1234.
9. Kawaguchi, Y., et al. 1994. Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis. Ann. Rheum. Dis. 53:506-510.
10. Feghali, C.A., Bost, K.L., Boulware, D.W., and Levy, L.S. 1994. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity. 17:309-318.
11. Luger, T.A., Stadler, B.M., Katz, S.I., and Oppenheim, J.J. 1981. Epidermal cell (keratinocyte) derived thymocyte activating factor. J. Immunol. 127:1493-1498.
12. Yamato, K., el-Hajjaoui, Z., and Koeffler, H.P. 1989. Regulation of level of IL-1 mRNA in fibroblasts. J. Cell. Physiol. 139:610-616.
13. Auron, P.E., et al. 1987. Studies on the molecular nature of human interleukin 1. J. Immunol. 138:1447-1456.
14. Mauviel, A., Temime, N., Charron, D., Loyau, G., and Pujol, J.-P. 1988. Interleukin-1a and b stimulate interleukin-1b gene expression in human dermal fibroblasts. Biochem. Biophys. Res. Commun. 156:1209-1214.
15. Elias, J.A., and Lentz, V. 1990. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol. 145:161-166.
16. Shroder, J.-M., Sticherling, M., Henneicke, H.H., Preissner, W.C., and Christophers, E. 1990. IL-1a or tumor necrosis factor-a stimulate release of three NAP/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J. Immunol. 144:2223-2232.
17. Last-Barney, K., Homon, C.A., Faanes, R.B., and Merluzzi, V.J. 1988. Synergistic and overlapping activities of tumor necrosis factor-a and IL-1. J. Immunol. 141:527-530.
18. Zucali, J.R., et al. 1986. Interleukin-1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J. Clin. Invest. 77:1857-1863.
19. Raines, E.W., Dower, S.K., and Ross, R. 1989. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 243:393-396.
20. Kawaguchi, Y. 1994. IL-1a gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin. Exp. Immunol. 97:445-450.
21. Mosley, B., et al. 1987. The interleukin-1 receptor binds the human interleukin-1a precursor but not the interleukin-1b precursor. J. Biol. Chem. 262:2941-2944.
22. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. 1980. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:581-590.
23. Kawaguchi, Y., et al. 1992. Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis. J. Rheumatol. 19:1710-1715.
24. Maier, J.A.M., Voulalas, P., Roeder, D., and Maciag, T. 1990. Extension of the life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science. 249:1570-1574.
25. Wang, A.M., Doyle, M.V., and Mark, D.F. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9721.
26. Burch, R.M., and Mahan, L.C. 1991. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice. J. Clin. Invest. 88:1190-1196.
27. van der Krol, A.R., Mol, J.N.M., and Stuitje, A.R. 1988. Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques. 6:958-976.
28. Marcus-Sekura, C.J. 1988. Techniques for using antisense oligodeoxyribonucleotides to study gene expression. Anal. Biochem. 172:289-295.
29. Walder, R.Y., and Walder, J.A. 1988. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proc Natl. Acad. Sci. USA. 85:5011-5015.
30. Boiziau, C., et al. 1991. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism. Nucleic Acids Res. 19:1113-1119.
31. Kawaguchi, Y., et al. 1993. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1b. Biochem. Biophys. Res. Commun. 190:154-161.
32. Kadono, T., Kikuchi, K., Ihn, H., Takehara, K., and Tamaki, K. 1998. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J. Rheumatol. 25:296-301.
33. Hasegawa, M., et al. 1998. Serum levels of IL-6, oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J. Rbeumatol. 25:308-313.
34. Gudbjornsson, B., et al. 1994. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjogren's syndrome. Ann. Rheum. Dis. 53:574-579.
35. Burch, R.M., and Mahan, L.C. 1991. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice. J. Clin. Invest. 88:1190-1196.
36. Stein, C.A., Subasinghe, C., Shinozuka, K., and Cohen, J.S. 1988. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16:3209-3221.
37. Kahari, V.M., Heino, J., and Vuorio, E. 1987. Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim. Biophys. Acta. 929:142-147.
38. Duncan, M.R., and Berman, B. 1991. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J. Invest. Dermatol. 97:686-692.
39. Kulozik, M., Hogg, A., Lankat-Buttgereit, B. and Krieg, T. 1990. Co-localization of transforming growth factor b2 with a1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest. 86:917-922.
40. Needleman, B.W., Wigley, F.M., and Stair, R.W. 1992. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor a, and interferon-g, levels in sera from patients with scleroderma. Arthritis Rheum. 35:67-72.